Reprocell Of Yokohama Develops Liver Cells Using iPS Technology
This article was originally published in PharmAsia News
Executive Summary
Japan National Biomedical Institute and bio venture firm Reprocell jointly developed liver cells using induced pluripotent stem cell technology